SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001104659-20-038458
Filing Date
2020-03-26
Accepted
2020-03-25 21:49:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM F-3 tm2013443d1_f3.htm F-3 540397
2 EXHIBIT 23.1 tm2013443d1_ex23-1.htm EX-23.1 6111
3 GRAPHIC tm2013443d1_f3sp1-img001.jpg GRAPHIC 14892
4 GRAPHIC tm2013443d1_f3sp1-img002.jpg GRAPHIC 13402
  Complete submission text file 0001104659-20-038458.txt   586971
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-3 | Act: 33 | File No.: 333-237389 | Film No.: 20743860
SIC: 2834 Pharmaceutical Preparations